Efficacy and Safety of Linagliptin in General Surgical Patients with Type 2 Diabetes: Linagliptin Surgery Trial

被引：0
作者：
Vellanki, Priyathama
Alexanian, Sara
Baldwin, David
Rasouli, Neda
Anzola, Isabel A.
Ramos, Clementina
Urrutia, Maria A.
Jones, Jocelyn
Modzelewski, Katherine
Ensminger, Elizabeth
Bakhtiari, Hoda F.
Pasquel, Francisco
Fayfman, Maya
Haw, Sonya
Peng, Limin
Umpierrez, Guillermo E.
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1254-P
引用
收藏
页码：A336 / A336
页数：1
相关论文
共 50 条
  • [21] Linagliptin In Type 2 Diabetes Mellitus
    Scott, Lesley J.
    [J]. DRUGS, 2011, 71 (05) : 611 - 624
  • [22] Safety and efficacy of linagliptin as add-on therapy to a sulphonylurea in inadequately controlled type 2 diabetes
    Lewin, A. J.
    Arvay, L.
    Liu, D.
    Patel, S.
    Woerle, H. -J.
    [J]. DIABETOLOGIA, 2010, 53
  • [23] Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes
    Araki, E.
    Kawamori, R.
    Inagaki, N.
    Watada, H.
    Hayashi, N.
    Horie, Y.
    Sarashina, A.
    Thiemann, S.
    von Eynatten, M.
    Dugi, K.
    Woerle, H. -J.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (04) : 364 - 371
  • [24] Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study
    Bae, Jaehyun
    Song, Kee-Ho
    Park, Jong Suk
    Lee, Jae Hyuk
    Jeong, In-Kyung
    Kim, Hyun Jin
    Lim, Young-Hyo
    Cho, Jae-Hyoung
    Choi, Sung Hee
    Chung, Yoon-Sok
    Kang, Eun Seok
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (05) : 1208 - 1212
  • [25] A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes
    Gallwitz, Baptist
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (12) : 1399 - 1405
  • [26] Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
    Barnett, Anthony H.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 149 - 159
  • [27] Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes
    Haak, Thomas
    [J]. CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2015, 8 : 1 - 6
  • [28] Empagliflozin/Linagliptin: Combination therapy in patients with type 2 diabetes
    Tan, Xueying
    Hu, Jingbo
    [J]. ANNALES D ENDOCRINOLOGIE, 2016, 77 (05) : 557 - 562
  • [29] Efficacy and safety of linagliptin plus insulin in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
    Yang, Wenying
    Shen, Jie
    Ye, Binqi
    Qi, Sheng
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [30] Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes
    Sarashina, Akiko
    Friedrich, Christian
    Crowe, Susanne
    Patel, Sanjay
    Graefe-Mody, Ulrike
    Hayashi, Naoyuki
    Horie, Yoshiharu
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (05): : 744 - 750
12345